Notably, MSUT2 KO mice injected with PSP- and CBD-tau also showed a decrease in neuronal tau pathology, but not astrocytic tau pathology, suggesting that reduction of MSUT2 does not affect glial tau seeding and spreading. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.